Stockreport

UK NICE backs Exact's Oncotype cancer genomic test Fri, May 10, 2024, 3:22 PM GMT+2 2 min read 0 In this article: Advertisement Up next These 2 ‘Strong Buy' Penny Stocks Could Surge Over 4...

Protara Therapeutics, Inc.  (TARA) 
PDF recurrence score test to help physicians manage chemotherapy care for patients with breast cancer. The UK agency recommends the use of the breast recurrence score test [Read more]